Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of ustekinumab, infliximab and combination therapy in moderately to severely active ulcerative colitis - a study protocol of a randomized, multicenter, head-to-head COMBO-UC trial.
Talar-Wojnarowska R, Fabisiak A, Zatorski H, Płoszka K, Błaziak K, Fendler W, Rydzewska G, Małecka-Wojciesko E, Eder P. Talar-Wojnarowska R, et al. Among authors: eder p. Front Med (Lausanne). 2024 Sep 19;11:1458998. doi: 10.3389/fmed.2024.1458998. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39364021 Free PMC article.
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study.
Dragoni G, Innocenti T, Amiot A, Castiglione F, Melotti L, Festa S, Savarino EV, Truyens M, Argyriou K, Noviello D, Molnar T, Bouillon V, Bezzio C, Eder P, Fernandes S, Kagramanova A, Armuzzi A, Oliveira R, Viola A, Ribaldone DG, Drygiannakis I, Viganò C, Calella F, Gravina AG, Pugliese D, Chaparro M, Ellul P, Vieujean S, Milla M, Caprioli F; “TOFA-poSTOP” Study Group. Dragoni G, et al. Among authors: eder p. Am J Gastroenterol. 2024 Aug 1;119(8):1525-1535. doi: 10.14309/ajg.0000000000002676. Epub 2024 Feb 2. Am J Gastroenterol. 2024. PMID: 38305302 Free PMC article.
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium.
Lenti MV, Ribaldone DG, Borrelli de Andreis F, Vernero M, Barberio B, De Ruvo M, Savarino EV, Kav T, Blesl A, Franzoi M, Gröchenig HP, Pugliese D, Ianiro G, Porcari S, Cammarota G, Gasbarrini A, Spagnuolo R, Ellul P, Foteinogiannopoulou K, Koutroubakis I, Argyriou K, Cappello M, Jauregui-Amezaga A, Demarzo MG, Silvestris N, Armuzzi A, Sottotetti F, Bertani L, Festa S, Eder P, Pedrazzoli P, Lasagna A, Vanoli A, Gambini G, Santacroce G, Rossi CM, Delliponti M, Klersy C, Corazza GR, Di Sabatino A; European Consortium for the study of immune checkpoint inhibitor-induced colitis. Lenti MV, et al. Among authors: eder p. ESMO Open. 2024 Jul;9(7):103632. doi: 10.1016/j.esmoop.2024.103632. Epub 2024 Jul 5. ESMO Open. 2024. PMID: 38970840 Free PMC article.
Prophylactic Versus Endoscopy-driven Treatment of Crohn's Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study].
Geldof J, Truyens M, Hanssens M, Van Gucht E, Holvoet T, Elorza A, Bouillon V, Barros S, Martins V, Argyriou K, Potamianos S, Diculescu M, Stroie T, Bossuyt P, Moens A, Theodoraki E, Koutroubakis IE, Pedro J, Fernandes S, Nikolaou P, Karmiris K, Baert FJ, Ferreiro-Iglesias R, Peeters H, Claeys S, Casanova MJ, Eder P, Porter RJ, Arnott I, Karakan T, Mesonero F, Revés J, Van Dyck E, Jauregui-Amezaga A, Mañosa M, Rivière P, Marquez Mosquera L, Portela F, Pimentel R, Lobaton T. Geldof J, et al. Among authors: eder p. J Crohns Colitis. 2024 Aug 14;18(8):1202-1214. doi: 10.1093/ecco-jcc/jjae011. J Crohns Colitis. 2024. PMID: 38243807
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection.
Goren I, Fallek Boldes O, Boldes T, Knyazev O, Kagramanova A, Limdi JK, Liu E, Sethi-Arora K, Holvoet T, Eder P, Bezzio C, Saibeni S, Vernero M, Alimenti E, Chaparro M, Gisbert JP, Orfanoudaki E, Koutroubakis IE, Pugliese D, Cuccia G, Calviño Suarez C, Ribaldone DG, Veisman I, Sharif K, Aratari A, Papi C, Mylonas I, Mantzaris GJ, Truyens M, Lobaton T, Nancey S, Castiglione F, Nardone OM, Calabrese G, Karmiris K, Velegraki M, Theodoropoulou A, Shitrit AB, Lukas M, Vojtechová G, Ellul P, Bugeja L, Savarino EV, Fischler TS, Dotan I, Yanai H. Goren I, et al. Among authors: eder p. J Crohns Colitis. 2024 Oct 21:jjae161. doi: 10.1093/ecco-jcc/jjae161. Online ahead of print. J Crohns Colitis. 2024. PMID: 39435855
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg).
Olmedo L, Calvet X, Gené E, Bordin DS, Voynovan I, Castro-Fernandez M, Pabón-Carrasco M, Keco-Huerga A, Perez-Aisa Á, Lucendo AJ, Rodrigo L, Sarsenbaeva AS, Khlinov IB, Fadieienko G, Zaytsev O, Lanas Á, Martínez-Domínguez SJ, Alfaro E, Jonaitis L, Núñez Ó, Pellicano R, Hernández L, Gridnyev O, Kupcinskas J, Gasbarrini A, Boltin D, Niv Y, Babayeva G, Marcos-Pinto R, Tepes B, Venerito M, Papp V, Lerang F, Leja M, Phull PS, Marlicz W, Doulberis M, Smith SM, Milivojevic V, Kunovsky L, Mestrovic A, Matysiak-Budnik T, Simsek H, Cano-Català A, Puig I, Moreira L, Parra P, Nyssen OP, Megraud F, O'Morain C, Gisbert JP; Hp-EuReg investigators*. Olmedo L, et al. Gut. 2024 Dec 10;74(1):15-25. doi: 10.1136/gutjnl-2024-332804. Gut. 2024. PMID: 39461739 Free PMC article.
Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance.
Bujanda L, Nyssen OP, Ramos J, Bordin DS, Tepes B, Perez-Aisa A, Pavoni M, Castro-Fernandez M, Lerang F, Leja M, Rodrigo L, Rokkas T, Kupcinskas J, Jonaitis L, Shvets O, Gasbarrini A, Simsek H, Phull PS, Buzás GM, Machado JC, Boltin D, Boyanova L, Tonkić A, Marlicz W, Venerito M, Vologzanina L, Fadieienko GD, Fiorini G, Resina E, Muñoz R, Cano-Català A, Puig I, García-Morales N, Hernández L, Moreira L, Megraud F, Morain CO, Montes M, Gisbert JP; Hp-EuReg investigators; Hp-EuReg investigators. Bujanda L, et al. Am J Gastroenterol. 2024 Apr 1;119(4):646-654. doi: 10.14309/ajg.0000000000002600. Epub 2023 Nov 17. Am J Gastroenterol. 2024. PMID: 37983769
The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study.
Amiot A, Rahier JF, Baert F, Nahon S, Hart A, Viazis N, Biancone L, Domenech E, Reenears C, Peyrin-Biroulet L, Beaugerie L, Burisch J; I-CARE collaborator group. Amiot A, et al. J Crohns Colitis. 2023 Jan 27;17(1):37-48. doi: 10.1093/ecco-jcc/jjac091. J Crohns Colitis. 2023. PMID: 35767639 Free PMC article.
Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II).
Liebert A, Kłopocka M, Michalak A, Cichoz-Lach H, Talar-Wojnarowska R, Domz Ał-Magrowska D, Konecki Ł, Filipiuk A, Krogulecki M, Kopertowska-Majchrzak M, Stawczyk-Eder K, Waszak K, Eder P, Zagórowicz E, Smoła I, Wojciechowski K, Drygała S. Liebert A, et al. Among authors: eder p. Therap Adv Gastroenterol. 2024 Nov 20;17:17562848241293938. doi: 10.1177/17562848241293938. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39575158 Free PMC article.
190 results